Gene expression relevant to osteoclastogenesis in the synovium and bone marrow of mature rats with collagen-induced arthritis

被引:17
作者
Kishimoto, Y [1 ]
Fukumoto, S
Nishihara, S
Mizumura, H
Hirai, K
Teshima, R
机构
[1] Tottori Univ, Fac Med, Dept Orthoped Surg, Yonago, Tottori 6838504, Japan
[2] Tottori Univ, Fac Med, Dept Pathol & Microbiol, Div Mol Med Zool, Yonago, Tottori 6838504, Japan
关键词
osteoclastogenesis; collagen-induced arthritis; synovium; bone marrow; RANKL; RANK; OPG; inflammatory cytokines;
D O I
10.1093/rheumatology/keh395
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To investigate gene expression relevant to osteoclastogenesis in the synovium and bone marrow during the development of collagen-induced arthritis (CIA) in mature rats. Methods. Total messenger RNAs (mRNAs) were obtained from CIA synovium and bone marrow after immunization. First, reverse transcriptase-polymerase chain reactions (RT-PCR) were carried out to detect the mRNA encoding receptor activator of NF-kappaB (RANK), RANK ligand (RANKL), osteoprotegerin (OPG), tumour necrosis factor-alpha (TNF-alpha), interleukin (IL)-1beta, IL-6 and the osteoclast markers tartrate-resistant acid phosphatase (TRAP) and cathepsin K. Secondly, the genes detected clearly by RT-PCR were quantified using real-time PCR. Results. In the synovium, expression of all genes was confirmed by specific single bands in RT-PCR. In real-time PCR, the expression levels of TNF-alpha, IL-1beta, IL-6, RANKL, TRAP and cathepsin K mRNA increased, whereas the expression levels of RANK and OPG were unchanged and decreased respectively. RANKL expression was highly correlated with the two osteoclast markers. In the bone marrow, RT-PCR did not clearly detect the expression of IL-6, RANKL or OPG mRNA. Quantitative real-time PCR showed that TNF-alpha, RANK and TRAP mRNA expression did not change significantly with time, and that IL-1beta and cathepsin K changed slightly compared with those in the synovium. Conclusions. In the early stages of arthritis, synovial RANKL is closely involved in osteoclastogenesis, and various changes in synovial cytokines, including down-regulation of OPG, probably accelerate osteoclast formation. In contrast, cytokine mRNA in the bone marrow showed little fluctuation. We suggest that synovial cytokines affect osteoclastogenesis not only in the synovium but in the bone marrow.
引用
收藏
页码:1496 / 1503
页数:8
相关论文
共 45 条
[1]   CYTOKINES AND CYTOKINE INHIBITORS OR ANTAGONISTS IN RHEUMATOID-ARTHRITIS [J].
AREND, WP ;
DAYER, JM .
ARTHRITIS AND RHEUMATISM, 1990, 33 (03) :305-315
[2]   Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts [J].
Azuma, Y ;
Kaji, K ;
Katogi, R ;
Takeshita, S ;
Kudo, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (07) :4858-4864
[3]   Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis [J].
Bolon, B ;
Shalhoub, V ;
Kostenuik, PJ ;
Campagnuolo, G ;
Morony, S ;
Boyle, WJ ;
Zack, D ;
Feige, U .
ARTHRITIS AND RHEUMATISM, 2002, 46 (12) :3121-3135
[4]   Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells [J].
Brändström, H ;
Björkman, T ;
Ljunggren, Ö .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 280 (03) :831-835
[5]   Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays [J].
Bustin, SA .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2000, 25 (02) :169-193
[6]  
CAULFIELD JP, 1982, LAB INVEST, V46, P321
[7]   New insights into the regulation of cathepsin K gene expression by osteoprotegerin ligand [J].
Corisdeo, S ;
Gyda, M ;
Zaidi, M ;
Moonga, BS ;
Troen, BR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 285 (02) :335-339
[8]   Bone mass changes of tibial and vertebral bones in young and adult rats with collagen-induced arthritis [J].
Enokida, M ;
Yamasaki, D ;
Okano, T ;
Hagino, H ;
Morio, Y ;
Teshima, R .
BONE, 2001, 28 (01) :87-93
[9]   Role of cytokines in rheumatoid arthritis [J].
Feldmann, M ;
Brennan, FM ;
Maini, RN .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :397-440
[10]  
Fujikawa Y, 1996, BRIT J RHEUMATOL, V35, P213